Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic User Fee Negotiations: Should Different Kinds Of ANDAs Pay More?

Executive Summary

The generic industry largely rejects one of the theoretical structures floated by FDA for an ANDA user fee program: paying more for reviews of complex drugs. But the concept does have support from many consumer advocates and at least one member of the Generic Pharmaceutical Association's board of directors, suggesting that the approach might continue to guide regulatory thinking even if it is not part of the final deal between industry and the agency.
Advertisement

Related Content

ANDA User Fees: Negotiators Close To Agreement, But Backlog Is Sticking Point
ANDA User Fees: Negotiators Close To Agreement, But Backlog Is Sticking Point
Generic User Fees Would Create 10-Month ANDA Review Time
Tiered And Backlog Generic User Fees Are Possible But Create Challenges For FDA
Tiered And Backlog Generic User Fees Are Possible But Create Challenges For FDA
Biosimilars: FDA Casts Wide Net For Creation Of User Fees
FDA's Buehler To Join Teva
Caring Agency Seeks Stable Partner For FOB User Fee Negotiations
GDUFA Timetable Unclear, But Negotiations Will Begin With Lots Of Agreement - Except For Mylan
Generic Drug Fees Could Be Based On Product Complexity

Topics

Advertisement
UsernamePublicRestriction

Register

PS052649

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel